New Current Report Filed with the SEC Disclosing Bankruptcy or Receivership: 8-K – EPIRUS Biopharmaceuticals, Inc. (0001135906) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing a bankruptcy or receivership. Details of the current report are:

8-K – EPIRUS Biopharmaceuticals, Inc. (0001135906) (Filer)
Filed: 2016-07-25 AccNo: 0001104659-16-134031 Size: 24 KB

Item 1.01: Entry into a Material Definitive Agreement

Item 1.02: Termination of a Material Definitive Agreement

Item 1.03: Bankruptcy or Receivership

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item 8.01: Other Events
Filing Date: 2016-07-25T11:31:38-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: